Osaic Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.3M | Buy |
57,863
+12,158
| +27% | +$904K | 0.01% | 1147 |
|
|
2025
Q1 | $3.31M | Sell |
45,705
-40,061
| -47% | -$2.9M | 0.01% | 1297 |
|
|
2024
Q4 | $5.88M | Buy |
85,766
+22,653
| +36% | +$1.55M | 0.01% | 946 |
|
|
2024
Q3 | $4.16M | Sell |
63,113
-26,351
| -29% | -$1.74M | 0.01% | 1163 |
|
|
2024
Q2 | $8.26M | Sell |
89,464
-17,442
| -16% | -$1.61M | 0.02% | 722 |
|
|
2024
Q1 | $10.2M | Sell |
106,906
-99,052
| -48% | -$9.46M | 0.02% | 677 |
|
|
2023
Q4 | $15.7M | Sell |
205,958
-143,984
| -41% | -$11M | 0.03% | 570 |
|
|
2023
Q3 | $24.2M | Buy |
349,942
+88,933
| +34% | +$6.16M | 0.04% | 472 |
|
|
2023
Q2 | $24.6M | Buy |
261,009
+1,401
| +0.5% | +$132K | 0.04% | 389 |
|
|
2023
Q1 | $21.5M | Buy |
259,608
+16,557
| +7% | +$1.37M | 0.04% | 428 |
|
|
2022
Q4 | $18.1M | Buy |
243,051
+33,037
| +16% | +$2.46M | 0.04% | 470 |
|
|
2022
Q3 | $17.4M | Sell |
210,014
-22,155
| -10% | -$1.83M | 0.04% | 432 |
|
|
2022
Q2 | $22.1M | Buy |
232,169
+19,641
| +9% | +$1.87M | 0.05% | 353 |
|
|
2022
Q1 | $27.5M | Sell |
212,528
-10,635
| -5% | -$1.38M | 0.05% | 329 |
|
|
2021
Q4 | $28.9M | Buy |
223,163
+32,539
| +17% | +$4.21M | 0.05% | 321 |
|
|
2021
Q3 | $21.6M | Buy |
190,624
+11,138
| +6% | +$1.26M | 0.05% | 372 |
|
|
2021
Q2 | $18.6M | Buy |
179,486
+6,509
| +4% | +$674K | 0.04% | 405 |
|
|
2021
Q1 | $14.5M | Sell |
172,977
-10,510
| -6% | -$879K | 0.03% | 449 |
|
|
2020
Q4 | $16.7M | Sell |
183,487
-18,251
| -9% | -$1.66M | 0.04% | 366 |
|
|
2020
Q3 | $16M | Buy |
201,738
+9,673
| +5% | +$767K | 0.05% | 333 |
|
|
2020
Q2 | $13.3M | Buy |
192,065
+4,154
| +2% | +$287K | 0.04% | 347 |
|
|
2020
Q1 | $11.1M | Buy |
+187,911
| New | +$11.1M | 0.05% | 345 |
|